Business
Perimeter Medical Imaging AI Reports First Quarter 2023 Financial Results and Provides Corporate Update
Perimeter Medical Imaging AI Reports First Quarter 2023 Financial Results and Provides Corporate ...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n \n \n \n Perimeter Medical Imaging AI Reports First Quarter 2023 Financial Results and Provides Corporate Update\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n Conference Call/Webcast Today at\n \n 5 pm ET\n \n \n \n \n \n \n \n TORONTO\n \n and\n \n DALLAS\n \n \n ,\n \n \n May 25, 2023\n \n \n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (\"Perimeter\" or the \"Company\") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today reported financial results for its first quarter ended\n \n March 31, 2023\n \n and provided a corporate update.\n \n \n \n \n \n \n \n \n \n \n \n Key Highlights\n \n \n \n \n \n Completed the first commercial placement of its flagship\n \n Perimeter S-Series OCT system in the state of\n \n Utah\n \n \n \n \n Initiated an\n \n additional clinical trial site\n \n at Baptist MD Anderson Cancer Center in\n \n Jacksonville, FL\n \n \n \n Appointed\n \n global industry leader\n \n Suzanne Foster\n \n \n – currently President of Beckman Coulter Life Sciences – as Chair of its Board of Directors\n \n \n Showcased Perimeter S-Series OCT at leading industry conferences including\n \n SSO 2023\n \n and\n \n ASBrS 2023\n \n \n \n \n \n Jeremy Sobotta\n \n , Perimeter's Chief Executive Officer stated, \"We completed a number of important milestones in our first quarter while continuing to advance and execute upon our planned commercial and clinical activities. Sales leads and demos of our flagship Perimeter S-Series OCT continue, resulting in our first commercial placement in the state of\n \n Utah\n \n . The highly engaged champions of our technology at these newest accounts continue to build upon our foundation of reference sites that drive our commercialization strategy.\"\n \n \n Mr. Sobotta added, \"Looking further ahead, we believe combining AI with our 'real-time' ultra-high-r...